Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 139-144

  Yamamoto, Nobuchika ^a   Kawamura, Ikuo ^a   Nishigaki, Fusako ^a   Tsujimoto, Susumu ^a   Naoe, Yoshinori ^a   Inami, Masamichi ^a   Elizabeth, Lacey ^a   Manda, Toshitaka ^a   Shimomura, Kyoichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Cachexia; Colon26; FR143430; Interleukin 1; TNF

Indexed keywords

2 (4 FLUOROPHENYL) 4,5,6,7 TETRAHYDRO 3 (4 PYRIDYL)PYRAZOLO[1,5 A]PYRIMIDINE; CHOLESTEROL; FATTY ACID; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CACHEXIA; CHOLESTEROL BLOOD LEVEL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR GROWTH;

ANIMALS; CACHEXIA; CELLS, CULTURED; COLONIC NEOPLASMS; CYTOKINES; HUMANS; LEUKOCYTES; MICE; MICE, INBRED BALB C; MONOCYTES; NEOPLASMS, EXPERIMENTAL; PYRAZOLES; PYRIMIDINES;

EID: 0031895855     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C. Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW and Tormey DC: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69: 491-497, 1980.
2. Curtis EB, Krech R and Walsh TD: Common symptoms in patients with advanced cancer. J Palliat Care 7: 25-29, 1991.
3. Lazo PA: Tumor-host metabolic interaction and cachexia. FEBS Lett 187: 189-192, 1985.
4. Mulligan HD, Beck SA and Tisdale MJ: Lipid metabolism in cancer cachexia. Br J Cancer 66: 57-61, 1992.
5. Smith KL and Tisdale MJ: Mechanism of muscle protein degradation in cancer cachexia. Br J Cancer 68: 314-318, 1993.
6. Soda K and Kawakami M: Cancer cachexia: Pathogenesis and possible role of cytokines. Ann Cancer Res Ther 3: 73-81, 1994.
7. Espat NJ, Copeland EM and Moldawer LL: Tumor necrosis factor and cachexia: A current perspective Surg Oncol 3: 255-262, 1994.
8. Costelli P, Carbo N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argiles JM and Baccino FM: Tumor necrosis factor-a mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993.
9. GreenbergAS, Nordan RP, McIntosh J, Calvo JC, Scow RO and Jablons D: Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adiposites: A possible role for interleukin 6 in cancer cachexia. Cancer Res 52: 4113-4116, 1992.
10. Kern KA and Norton JA: Cancer cachexia. J Parenter Enteral Nutr 12: 286-298, 1988.
11. Corbett TH, Griswold DP Jr, Robert BJ, Peckham JC and Schabel FM Jr: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35: 2434-2439, 1975.
12. Tanaka Y, Eda H, Tanaka T, Udayama T, Ishikawa T, Horii I, Ishizuka H, Kataoka T and Taguchi T: Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 50: 2290-2295, 1990.
13. Strassmann G, Fong M, Kenney JS and Jacob CO: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89: 1681-1684, 1992.
14. Strassmann G, Jacob CO, Evans R, Beall D and Fong M: Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to Interleukin-6- mediated cancer cachexia. J Immunol 148: 3674-3678, 1992.
15. Strassmann G, Masui Y, Chizzonite R and Fong M: Mechanisms of experimental cancer cachexia: Local involvement of Interleukin-1 in colon-26 tumor. J Immunol 150: 2341-2345, 1993.
16. Yamamoto N, Sakai F, Yamazaki H, Nakahara K and Okuhara M: Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 314: 137-142, 1996.
17. Von Roenn JH, Roth EL and Craig R: HIV-rclated cachexia. Potential mechanisms and treatment. Oncology 49 Suppl 2: 50-54, 1992.
18. Soda K, Kawakami M, Kashii A and Miyata M: Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer 62: 332-336, 1995.
19. Yasumoto K, Mukaida N, Harada A, Kuno K, Akiyama M, Nakashima E, Fujioka N, Mai M, Kasahara T, Fujimoto-Ouchi K, Mori K, Tanaka Y and Matsushima K: Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearingmice. Cancer Res 55; 921-927, 1995.
20. Jain RK: Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 9: 253-266, 1990.